Lb Pharmaceuticals Inc (LBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 250,173 | 22,978 |
| Marketable Securities | 45,040 | 5,021 |
| TOTAL | $308,432 | $28,879 |
| Non-Current Assets | ||
| PPE Net | 1,581 | 1,859 |
| Other Non-Current Assets | 2,921 | 2,796 |
| TOTAL | $4,502 | $4,655 |
| Total Assets | $312,934 | $33,534 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,127 | 2,320 |
| Accrued Expenses | 4,585 | 5,302 |
| TOTAL | $7,442 | $8,109 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 4,182 | 5,720 |
| TOTAL | $4,182 | $5,720 |
| Total Liabilities | $11,624 | $13,829 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 28,675 | N/A |
| Common Shares | 3 | 1 |
| Retained earnings | -129,528 | -104,323 |
| Other shareholders' equity | 168 | 111 |
| TOTAL | $301,310 | $19,705 |
| Total Liabilities And Equity | $312,934 | $33,534 |